Galapagos NV
GLPG
#4604
Rank
C$2.86 B
Marketcap
C$43.42
Share price
1.45%
Change (1 day)
11.88%
Change (1 year)

Market capitalization of Galapagos NV (GLPG)

Market cap: C$2.86 Billion

As of December 2025 Galapagos NV has a market cap of C$2.86 Billion. This makes Galapagos NV the world's 4604th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Galapagos NV from 2008 to 2025

End of year Market Cap

Year Marketcap Change
2025C$2.86 B10.83%
2024C$2.58 B-27.34%
2023C$3.55 B-10.39%
2022C$3.96 B-14.84%
2021C$4.65 B-43.61%
2020C$8.25 B-53.21%
2019C$17.64 B158.07%
2018C$6.83 B13.23%
2017C$6.03 B50.78%
2016C$4.00 B17.11%
2015C$3.41 B416.31%
2014C$0.66 B-0.73%
2013C$0.66 B18.72%
2012C$0.56 B54.89%
2011C$0.36 B-14.68%
2010C$0.42 B58.56%
2009C$0.26 B114.65%
2008C$0.12 B

End of Day market cap according to different sources

On Dec 17th, 2025 the market cap of Galapagos NV was reported to be:

C$2.86 Billion
by Nasdaq info icon info icon
C$2.86 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
AstraZeneca
AZN
C$383.66 B 13,309.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
C$697.80 B 24,289.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$161.80 B 5,555.49%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
C$545.90 B 18,980.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
C$0.14 B-94.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$303.67 B 10,514.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$47.48 B 1,559.85%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
C$135.31 B 4,629.58%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
C$341.12 B 11,823.09%๐Ÿ‡บ๐Ÿ‡ธ USA